Results 21 to 30 of about 593 (131)

Cutaneous Larva Migrans as a frequent problem in travellers [PDF]

, 2023
Dermatological disorders are among the most common complaints of patients seeking medical assistanceafter returning from trips to tropical countries.
Kuna, Anna, Olszański, Romuald, Sikorska, Katarzyna   +2 more
core   +2 more sources

Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study [PDF]

, 2022
Objectives In this study covering all of Turkey, we aimed to define cutaneous and systemic adverse reactions in our patient population after COVID-19 vaccination with the Sinovac/CoronaVac (inactivated SARS-CoV-2) and Pfizer/BioNTech (BNT162b2) vaccines.
Aktaş, Nurhan Döner, Albayrak, Hülya, Borlu, Murat, Cebeci Kahraman, Filiz, Savaş Erdoğan, Sevil, Türkmen, Dursun, Yılmaz, Ertan   +6 more
core   +1 more source

Incontinentia Pigmenti: A Case Report of a Complex Systemic Disease [PDF]

, 2017
Incontinentia Pigmenti is an uncommon X-linked genodermatosis, caused by mutations in the NEMO gene. It is a systemic disease that involves tissue of ectodermic and mesodermic origin, including cutaneous tissue, teeth, eyes and the central nervous system,
Gianfaldoni, Serena, Lotti, Torello, Tchernev, Georgi, Wollina, Uwe   +3 more
core   +3 more sources

URTICÁRIA PAPULAR BOLHOSA – CASO CLÍNICO E BREVE REVISÃO DA LITERATURA [PDF]

, 2013
Papular urticaria (PU), also known as prurigo strophulus, is a relatively common skin disorder of chil- dhood caused by hypersensitivity to a variety of bites, including those of mosquitoes, fleas, bedbugs and others insects.
Azevedo, Filomena, Bettencourt, Herberto, Martins, Paulo, Pedrosa, Ana, Ássimos, Isabella   +4 more
core   +2 more sources

An Atypical Presentation of Lichen Planus‐Like Reaction from Pembrolizumab

Case Reports in Dermatological Medicine, Volume 2019, Issue 1, 2019., 2019
Introduction. With the advent of immunotherapy, a new subtype of side effects called IRAEs or immune related adverse effects have become more common. They may present in various organ systems as colitis, pneumonitis, hypophysitis, and thyroiditis and commonly as dermatological reactions. Case.
Matthew Lee, Nagashree Seetharamu, Soner Uzun   +2 more
wiley   +1 more source

Antiviral Drug Allergy [PDF]

, 2014
Antiviral drugs used to treat HIV and hepatitis C are common causes of delayed drug hypersensitivities for which many of the more severe reactions have been recently shown to be immunogenetically mediated such as abacavir hypersensitivity where HLA-B*57 ...
Milpied-Homsi, B., Moran, E.M., Phillips, E.J.   +2 more
core   +1 more source

Wells syndrome: clinical findings and management in a large cohort of 48 patients

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives: Wells syndrome (WS) is a rare inflammatory skin disorder typically characterized by erythematous, edematous, and pruritic plaques. Despite its distinct histopathological features, WS remains an underdiagnosed disease due to its variable clinical presentations and overlap with other dermatological conditions.
Marco Adriano Chessa, Silvia Robuffo, Tullio Brunetti, Luca Rapparini, Bianca Maria Piraccini, Cosimo Misciali, Beatrice Raone, Iria Neri, Federica Filippi   +8 more
wiley   +1 more source

Drug Hypersensitivity: A Correlation Study From Histopathology to Clinic

JEADV Clinical Practice, Volume 5, Issue 1, Page 124-131, March 2026.
ABSTRACT Background Drug hypersensitivity (DH) can present with varied clinical and pathological manifestations that may mislead the referring physician. Available data regarding the concordance between pathological diagnosis and clinical findings in DH are scarce.
Olivier Philip, Morgane Stichelbout, Marie Verhasselt‐Crinquette, Baptiste Mille, Delphine Staumont‐Sallé, Frédéric Dezoteux   +5 more
wiley   +1 more source

The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease [PDF]

, 2018
Bullous pemphigoid (BP) is an autoimmune blistering disease which carries a significant mortality and morbidity. While historically BP has been characterized as an IgG driven disease mediated by anti-BP180 and BP230 IgG autoantibodies, developments in ...
Akasheh, Akuthota, Alam, Amber, Amber, Amber, Amber, Amber, Arbesman, Asashima, Bacon, Bagci, Bakker, Benzaquen, Bernard, Bernard, Bertram, Bieber, Blanchet, Blocker, Bonciani, Borrego, Bowszyc-Dmochowska, Brick, Bruijnzeel, Budinger, Bushkell, Bystrom, Caproni, Carlens, Chang, Charneux, Chijiwa, Chu, Chu, Cortjens, Costello, Coyle, Crotty, Curran, Cynkier, Czech, D'Auria, D'Auria, Davis, Davoine, de, Delaporte, della, Di, Dillon, Dillon, Dopp, Dresow, Dubertret, Dufour, Durcan, Dvorak, Dvorak, Endo, Engineer, Engmann, Fairley, Fajac, Feld, Feliciani, Forsti, Foster, Freire, Frezzolini, Frezzolini, Friedman, Gearing, Ghohestani, Giomi, Giusti, Gounni, Gras, Gu, Gu, Gudi, Gunther, Gunther, Hashimoto, Hayakawa, Hertl, Horikawa, Hurskainen, Inaoki, Ingen-Housz-Oro, Iryo, Iwata, Izumi, Jacoby, Jean-Baptiste, Johansson, Joly, Jung, Kameyoshi, Kasahara-Imamura, Kato, Keller, Kelly, Kershenovich, Kikuchi, Kinet, Kingham, Kridin, Kridin, Kunsleben, Langan, Le-Carlson, Lee, Lee, Lee, Lim, Lin, Lin, Lingblom, Liu, Liu, Liu, Liu, Long, Lopez, Lucey, Mackay, Marazza, Marzano, Meng, Messingham, Messingham, Mihai, Miyasato, Mondino, Moore, Morgan, Morgan, Moriuchi, Nakashima, Navarro, Nishihara, Nishioka, O'Connell, O'Connor, O'Donnell, Odemuyiwa, Okada, Okada, Oswald, Pavlovic, Pomponi, Provost, Raap, Rot, Rothenberg, Rudrich, Salz, Saniklidou, Sasaoka, Schall, Scheman, Schmidt, Schmidt, Schmidt, Schmidt, Schmidt, Schroder, Serwin, Shi, Shrikhande, Simon, Simon, Spencer, Stahle-Backdahl, Stavropoulos, Sun, Takamori, Tedeschi, Thomas, Trautmann, Tsuda, Tukaj, Ujiie, van, Van, Verjan, Verraes, von, Wakugawa, Wallengren, Walsh, Wang, Watanabe, Wen, Wiehler, Xenakis, Yamashita, Yang, Yang, Ying, Yoshida, Young, Yu, Zone   +204 more
core   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Med Research, Volume 1, Issue 3, Page 322-358, December 2025.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo   +8 more
wiley   +1 more source